1. Open Label Phase 1b in Gastric Cancer, in Combination with Chemotherapy (HER-Vaxx), Recruiting in Asia & Eastern Europe.

More Information Here


2. Open Label Phase 2, HER2 Positive (over expression of HER2 receptor) in Various Indications Recruiting at Ohio State University.

More Information Here